Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating LCAR-HL30 in adults with relapsed or refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma is…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial of temsirolimus for relapsed/refractory Hodgkin lymphoma was terminated; the update does not provide trial results.
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma [NA]
This document provides an update on a clinical trial evaluating whole-body diffusion-weighted MRI for staging and predicting treatment respo…
-
CLINICAL_TRIALS withdrawal · 2024-07-08Clinical Trial Update: GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma [Phase 1, Phase 2]
The GEMHDM2014 trial evaluating Gem-HDM HDT and autologous stem cell transplant for relapsed/refractory lymphoma has been terminated after P…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) [Phase 2]
Phase 2 study results of Brentuximab Vedotin in Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphoma have been completed. The res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant [Phase 1, Phase 2]
This clinical trial update examines using CD34+ malignant stem cell selection for patients receiving allogeneic stem cell transplants in Pha…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma [Phase 2]
This is a Phase II clinical trial evaluating nivolumab monotherapy for relapsed or refractory Hodgkin lymphoma, sponsored by University Coll…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma [Phase 3]
A Phase 3 clinical trial update evaluating Fludeoxyglucose F-18 PET/CT imaging to assess chemotherapy response in newly diagnosed Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) [Phase 2]
Phase 2 pediatric trial of Genistein for various cancers was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers [Phase 2]
A Phase 2 clinical trial update on haploidentical stem cell transplantation for multiple hematologic cancers, with the study status reported…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: A Study of Anti-PD-1 AK105 in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial update for AK105 (anti-PD-1) in relapsed or refractory classic Hodgkin lymphoma completed phase 1/2.
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial assessing camidanlumab tesirine (ADCT-301) for relapsed or refractory Hodgkin lymphoma has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL) [Phase 1, Phase 2]
Clinical trial update for BrEPEM-LH-22017 in older patients with untreated Hodgkin lymphoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer [Phase 2]
Phase 2 trial evaluating romiplostim to treat low platelets after chemotherapy and autologous hematopoietic cell transplantation in people w…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial of PD-1 antibody SHR-1210 in adults with relapsed or refractory classic Hodgkin's lymphoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant [Phase 1]
Phase 1 trial evaluating the CMV-MVA Triplex vaccine given to stem cell donors to prevent cytomegalovirus viremia in recipients of allogenei…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy [Phase 2]
Phase 2 clinical trial update for MGTA-456 in high-risk hematologic malignancies; results were posted in 2024 and the study is currently act…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy with or without radiation in low and intermediate risk Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: BV-AVD-R Treatment Children Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update for BV-AVD-R in pediatric Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma [Phase 2]
A Phase 2 trial of brentuximab vedotin in classical Hodgkin lymphoma was terminated, with results posted in December 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating prologolimab as monotherapy or with bendamustine for relapsed/refractory classical Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma [Phase 4]
A Phase 4 clinical trial comparing surgery alone versus surgery with additional systemic therapy regimens for stage IA/IIA nodular lymphocyt…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study [Phase 2]
Phase 2 clinical trial update evaluating avelumab as frontline treatment for advanced classical Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma [Phase 3]
Phase 3 trial evaluating PET scans to plan treatment in patients undergoing combination chemotherapy for stage IA or stage IIA Hodgkin lymph…
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
A completed clinical trial evaluating cardiac magnetic resonance imaging in patients with non-Hodgkin lymphoma or Hodgkin lymphoma receiving…